Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
09 November 2022
Closing Date:
12 December 2022
Location(s):
PL82 Podkarpackie (PL Poland/POLSKA)
Description:
Supply of antibiotics, antiviral and antifungal drugs for medical entities of the Podkarpackie Voivodeship

1. The subject of the contract is the successive supply of antibiotics, antiviral drugs and

antifungal to the entities listed in Section I.1 of the notice (with the exception of:

Podkarpackie Medical Center in Rzeszów Independent Public Health Care Institution).

A detailed description of the subject of the contract is included in Annex 4 to the Specification of Conditions

Orders (SWZ).

2. 2. The complete offer consists of (obligatory):

1. A tender drawn up in accordance with the model of Annex 1 to the SWZ. Offer form.

2. Completed Offer and price form in accordance with the template constituting Annex 4 to the SWZ

3. Declaration in the form of the Single European Procurement Document referred to in Chapter XVII, point 1 of the SWZ – drawn up and submitted in accordance with the requirements of the ESP (Annex 2 to the SWZ)

4. Declaration referred to in Chapter XVII, point 6.2 of the SWZ according to Annex 7 to the SWZ, if applicable

5. Declaration on the absence of grounds for exclusion according to Annex 8 to the SWZ

Package 1

The subject of the order is the successive delivery of antiviral drugs in the amount specified in Package 1

(Annex 4 to swz).

Package 10

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 10

(Annex 4 to the SWZ)

Package 11

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 11

(Annex 4 to the SWZ)

Package 12

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 12

(Annex 4 to the SWZ)

Package 13

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 13

(Annex 4 to the SWZ)

Package 14

The subject of the order is the successive delivery of antiviral drugs in the amount specified in Package 14

(Annex 4 to the SWZ)

Package 15

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 15

(Annex 4 to the SWZ)

Package 16

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 16

(Annex 4 to the SWZ)

Package 17

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 17

(Annex 4 to the SWZ)

Package 18

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 18

(Annex 4 to the SWZ)

Package 19

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 19

(Annex 4 to the SWZ)

Package 2

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 2

(Annex 4 to swz).

Package 20

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 20

(Annex 4 to the SWZ)

Package 21

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 21

(Annex 4 to the SWZ)

Package 22

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 22

(Annex 4 to the SWZ)

Package 23

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 23

(Annex 4 to the SWZ)

Package 24

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 24

(Annex 4 to the SWZ)

Package 25

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 25

(Annex 4 to the SWZ)

Package 26

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 26

(Annex 4 to the SWZ)

Package 27

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 27

(Annex 4 to the SWZ)

Package 28

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 28

(Annex 4 to the SWZ)

Package 29

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 29

(Annex 4 to the SWZ)

Package 3

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 3

(Annex 4 to swz).

Package 30

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 30

(Annex 4 to the SWZ)

Package 31

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 31

(Annex 4 to the SWZ)

Package 32

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 32

(Annex 4 to the SWZ)

Package 33

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 33

(Annex 4 to the SWZ)

Package 34

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 34

(Annex 4 to the SWZ)

Package 35

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 35

(Annex 4 to the SWZ)

Package 36

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 36

(Annex 4 to the SWZ)

Package 37

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 37

(Annex 4 to the SWZ)

Package 38

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 38

(Annex 4 to the SWZ)

Package 39

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 39

(Annex 4 to the SWZ)

Package 4

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 4

(Annex 4 to swz).

Package 40

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 40

(Annex 4 to the SWZ)

Package 41

The subject of the order is the successive delivery of antiviral drugs in the amount specified in Package 41

(Annex 4 to the SWZ)

Package 42

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 42

(Annex 4 to the SWZ)

Package 43

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 43

(Annex 4 to the SWZ)

Package 44

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 44

(Annex 4 to the SWZ)

Package 45

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 45

(Annex 4 to the SWZ)

Package 46

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 46

(Annex 4 to the SWZ)

Package 47

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 47

(Annex 4 to the SWZ)

Package 48

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 48

(Annex 4 to the SWZ)

Package 49

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 49

(Annex 4 to the SWZ)

Package 5

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 5

(Annex 4 to swz).

Package 50

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 50

(Annex 4 to the SWZ)

Package 51

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 51

(Annex 4 to the SWZ)

Package 52

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 52

(Annex 4 to the SWZ)

Package 53

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 53

(Annex 4 to the SWZ)

Package 54

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 54

(Annex 4 to the SWZ)

Package 55

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 55

(Annex 4 to the SWZ)

Package 56

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 56

(Annex 4 to the SWZ)

Package 57

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 57

(Annex 4 to the SWZ)

Package 58

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 58

(Annex 4 to the SWZ)

Package 59

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 59

(Annex 4 to the SWZ)

Package 6

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 6

(Annex 4 to swz).

Package 60

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 60

(Annex 4 to the SWZ)

Package 61

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 61

(Annex 4 to the SWZ)

Package 62

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 62

(Annex 4 to the SWZ)

Package 63

The subject of the order is the successive delivery of antiviral drugs in the amount specified in Package 63

(Annex 4 to the SWZ)

Package 64

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 64

(Annex 4 to the SWZ)

Package 65

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 65

(Annex 4 to the SWZ)

Package 66

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 66

(Annex 4 to the SWZ)

Package 67

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 67

(Annex 4 to the SWZ)

Package 68

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 68

(Annex 4 to the SWZ)

Package 69

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 69

(Annex 4 to the SWZ)

Package 7

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 7

(Annex 4 to swz).

Package 70

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 70

(Annex 4 to the SWZ)

Package 71

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 71

(Annex 4 to the SWZ)

Package 72

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 72

(Annex 4 to the SWZ)

Package 73

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 73

(Annex 4 to the SWZ)

Package 74

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 74

(Annex 4 to the SWZ)

Package 75

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 75

(Annex 4 to the SWZ)

Package 8

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 8

(Annex 4 to the SWZ)

Package 9

The subject of the contract is the successive delivery of antiviral drugs in the amount specified in Package 9

(Annex 4 to the SWZ)

Download full details as .pdf
The Buyer:
Podkarpackie Centrum Medyczne w Rzeszowie Samodzielny Publiczny Zakład Opieki Zdrowotnej
CPV Code(s):
33600000 - Pharmaceutical products